Predictive Factors for Progression to Severe Pulmonary Tuberculosis in Patients with Concurrent HIV/AIDS and Type 2
Bennan Zhao1, Jun Kang1, Qing Du2
1The First Ward of Internal Medicine, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, People's Republic of China.
Purpose:
The concurrent of HIV/AIDS, type 2 diabetes mellitus (T2D), and pulmonary tuberculosis (PTB) is a considerable public health challenge. This study aims to develop and validate a predictive model for the progression to severe PTB in patients with these three specific comorbidities.
Patients And Methods:
A total of 114 patients with all three conditions-HIV/AIDS, T2D, and newly diagnosed PTB-who were admitted to the Public Health Clinical Center of Chengdu between 2018 and 2025, were enrolled as study subjects. We collected general demographic information of the research subjects, as well as laboratory indicators, TB etiological test results, and lung CT scans. First, subjects were divided into severe and non-severe PTB groups according to diagnostic criteria met during hospitalization, the Least Absolute Shrinkage and Selection Operator (LASSO) analysis was used to screen for predictors. Second, a multivariate logistic regression was used to build the predictive model. The model was evaluated using the receiver operating characteristic (ROC) curve, and calibration curve.
Results:
Binary logistic regression revealed that admission ALB, NLR, and D-Dimer were independently associated with progression to severe PTB. ALB (OR=0.906, 95% CI: 0.822-0.998) served as a protective factor, while NLR (OR=1.234, 95% CI: 1.075-1.417) and D-Dimer (OR=1.500, 95% CI: 1.113-2.021) were risk factors. The area under the curve (AUC) of the model incorporating three variables was 0.892 (95% CI: 0.830-0.955). Internal validation using Bootstrap resampling (1000 iterations) yielded a concordance index of 0.892 (95% CI: 0.825-0.946), confirming the robustness of its discriminative power.
Conclusion:
This study established a predictive model for progression to severe PTB in patients with these three specific comorbidities. Due to the lack of external validation, the clinical utility of this model remains to be further validated by multicenter studies.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis


